>> Official Responses

The British Association of Dermatologists is invited to comment on a large number of consultation documents each year. These documents are issued by Government Departments, regulatory bodies and various other organisations around the UK.

Our full responses to consultation documents are listed below:

APPGS skin cancer enquiry, response re. provision of cancer services across the UK (March 2008)
APPGS commissioning enquiry, BAD submission (January 2008)
BAD response to Lord Darzi's interim report (January 2008)
BAD response to Review of NICE Technology Appraisal guidance no. 81; on the frequency of application of topical corticosteroids for eczema and Review of NICE Technology Appraisal guidance no. 82; on the use of pimecrolimus and tacrolimus for atopic dermatitis (eczema) (October 2007)
BAD response to proposed NICE Health Technology Appraisal, Topical negative pressure for wound management (October 2007)
BAD response to Using Job Planning and Appraisal to Satisfy Revalidation (October 2007)
BAD response to the Manual for Cancer Services: Consultation proforma draft skin cancer measures (October 2007)
BAD response to the "Challenges and Priorities for the MHRA" consultation (October 2007)
BAD response to the NICE single technology appraisal of Adalimumab for the treatment of psoriatic arthritis (September 2007) (Please note this evidence is similar to that given to NICE in November 2006)
BAD response to the MHRA consultation MLX 342: Proposals to amend Section 58 of the Medicines Act 1968 to enable UK Pharmacists to dispense prescription only medicines prescribed by Doctors and Dentists registered in European member states and Switzerland (September 2007)
BAD response to the NICE appraisal consultation document for infliximab for the treatment of adults with psoriasis (September 2007)
BAD response to the GMC Consultation on the the new guidance, Consent: Patients and Doctors Making Decisions Together (August 2007) 
BAD response to the Interventional Procedure Consultation Document from NICE on Grenz rays therapy for inflammatory skin conditions (July 2007)
BAD response to the NICE consultation on the first draft of the guideline on Atopic Eczema in Children (July 2007)
BAD additional response to the NICE consultation on the first draft of the guideline on Atopic Eczema in Chidren (July 2007)
BAD response to the Workforce Risk Assessment 2008/09 (July 2007)
BAD response to the draft guidance on Health in Strategic Environmental Assessment  (A copy of the Department of Health document can be accessed here) (June 2007)
BAD response to the Department of Health Commissioning framework for Health and Well being consultation (May 2007)
BAD response to the Healthcare Commission's Developing the annual health check 2007/2008 (May 2007)
BAD submission to the MMC Review Panel (April 2007)
BAD submission on Developing the Quality and Outcomes Framework (February 2007)
BAD response to the NICE consultation on Interventional Procedures Programme Methods Guide (February 2007)
BAD response to the Chief Medical Officer's call for radical overhaul of the expert witness programme (January 2007)
BAD response to a European Survey on the information needs of health professionals on allergic diseases (December 2006)
BAD response to NICE on Single Technology Appraisal for Adalimumab for the treatment of psoriatic arthritis (November 2006)
BAD response to NICE on Single Technology Appraisal for Inflximab for the treatment of psoriasis(November 2006)
UK Skin Cancer Working Party's response to Seeking Views Exercise on Going further on Cancer Waiting Times (November 2006)
BAD response to Seeking Views Exercise on Going further on Cancer Waiting Times (November 2006)
BAD response to the HIV Association's "Standards for HIV Services" (November 2006)
BAD response to the CfH questionnaire regarding the desired dermatology functionality for this initiative (October 2006)
BAD response to "Developing the Annual Health Check 2006/07" (June 2006)
BAD response to Department of Health consultation on Selection of Topics for work programme NICE (May 2006)
BAD response to NICE consultaiton on Surgical Site Infection (May 2006)
BAD response to NICE consultation on Adalimumab for the treatment of moderate to severe psoriatic arthritis (January 2006)
BAD response to NICE consultation on Leflunomide for the treatment of moderate to severe psortiatic arthritis (January 2006)
BAD Response to the Government White Paper: Our Health, Our Care, Our Say (January 2006)
NICE Review of Laser Therapy (December 2005)
BAD response to MHRA consultation on Fluconazole (October 2005)
Comments on the second draft of NICE Improving Outcomes for People with Skin Tumours including Melanoma (September 2005)
APPGS enquiry into the adequacy and equity of dermatology service provision (September 2005)
BAD response to the NPSA Methotrexate monitoring documents (August 2005)
General Medical Council draft guidance on Management for Doctors (July 2005)
NICE Efalizumab and Etanercept for the treatment of plaque psoriasis response (July 2005)
NICE Social Value Judgements (June 2005)
Nurse Prescribing MHRA-MLX320 (May 2005)
NICE Improving Outcomes for People with Skin Tumours including Melanoma (April 2005)
Pharmacist Prescribing MHRA-MLX321 (May 2005)
GMS Quality and Outcomes Framework Review (May 2005)
MMC Academic Response (December 2004)
Nurse Prescribing MCA Response (September 2001)